Loading...
Market
Will the Sacklers increase Purdue Pharma settlement beyond $6.5B by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official court documents or announcements from Purdue Pharma or the Sackler family
Story
Sacklers Increase Purdue Pharma Bankruptcy Settlement Contribution to $6.5 Billion from $6 Billion for Opioid Lawsuits
Jan 13, 2025, 11:35 AM
Members of the Sackler family, owners of Purdue Pharma, have agreed to increase their total contribution to a new bankruptcy settlement related to opioid lawsuits. The revised contribution will amount to approximately $6.5 billion, up from $6 billion under a previous plan. This adjustment comes as part of ongoing legal efforts to address the financial repercussions of the opioid crisis. Reports indicate that the Sacklers' overall wealth has increased since Purdue's bankruptcy filing, attributed to the appreciation of their investment assets and financial holdings.
View original story
Similar markets
Reach new settlements with other firms • 25%
Rebrand or restructure • 25%
File for bankruptcy again • 25%
No significant actions • 25%
Other • 25%
Johnson & Johnson • 25%
Teva Pharmaceuticals • 25%
Endo International • 25%
$1 billion to $1.5 billion • 25%
$1.5 billion to $2 billion • 25%
Less than $1 billion • 25%
More than $2 billion • 25%
$1 billion to $2 billion • 25%
More than $2 billion • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
